General Information
Takeda MDD 314 EXT
A Phase 3, Long-Term, Open-Label, Flexible-Dose, Extension Study Evaluating the Safety and Tolerability of Lu AA21004 (15 and 20 mg) in Subjects With Major Depressive Disorder
| Protocol | Lu AA21004_314 |
|---|---|
| Identifier | Lu AA21004_314 Site Number 4036 |
| UID | 5c113596-5e95-4271-b990-41ee554c2b33 |
| Status | Done - Archived |
| Phase | 3 |
| Category | Major Depressive Disorder / Adult |
| Launch Year | 2011 |
| NCT Number | - |
| Created | 2010-08-02 11:27 |
| Last Updated | 2010-08-02 11:27 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2012-02-15 | No |
| Enrollment Open | 2011-02-17 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2011-01-20 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2013-09-12 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohaupt, Stephen | SMohaupt | No |
| Recruiter | - | No | |
| Coordinator | Pereira, Cynthia | CPereira | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Takeda |
|---|---|
| Division | Takeda |
| Team | Takeda |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | 25285/42 |
|---|---|
| CRO | IQVIA RDS Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
